Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway

doi:10.1016/j.jpha.2019.09.005

Paper

Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway

Published Oct 4, 2019 · Xiaoli Liang, Yuan-Lin Huang, X. Pan

Journal of Pharmaceutical Analysis

Q1 SJR score

51

Citations

2

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation by inactivating NF-B and p38 MAPK signaling, suggesting potential therapeutic potential in influenza treatment.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-κB and p38 MAPK pathway

References

Citations